Locoid Scalp Lotion 0.1%

Pays: Malte

Langue: anglais

Source: Medicines Authority

Achète-le

Ingrédients actifs:

hydrocortisone butyrate 1 mg/g

Disponible depuis:

Astellas Pharma Europe B.V.

Code ATC:

D07AB02

DCI (Dénomination commune internationale):

hydrocortisone butyrate

forme pharmaceutique:

cutaneous solution

Statut de autorisation:

Authorised

Date de l'autorisation:

2005-09-23

Notice patient

                                scalp lotion 0.1%
Information for the user
We advise you to read this package insert, also if you have used
Locoid lotion before. 
The information may have changed.
GENERAL GUIDELINES
•  This medicine has been prescribed to you by your doctor. You
should therefore 
strictly follow his/her directions. 
   If you have any questions, please consult your doctor or the
pharmacist who 
supplied the medicine.
•  Never give your medicines to other people, and never use other
people’s 
medicines yourself.
•  Always make sure that you are using the proper medicine.
•  Do not keep any medicine you no longer need. Do not throw
medicines away but 
return them to your pharmacist.
•  In case of complaints always mention the batch number (see
package).
Council Of Arab Health Ministers
Union Of Arab Pharmacists
DATE OF LAST REVISION
May 2014
LOCOID
®
142652
WHAT IS LOCOID LOTION AND HOW DOES 
IT WORK?
_Composition_
Locoid lotion contains as active 
ingredient 1 mg hydrocortisone 
17-butyrate per gram.
The other ingredients are: isopropanol, 
glycerol, povidone, citric acid, sodium 
citrate and purified water.
_What does Locoid lotion look like and _
_how is it supplied?_
Locoid lotion is a clear colourless liquid 
which is packed in bottles of 30 ml. 
The bottle is packed in a yellow/grey/ 
white box imprinted Locoid lotion 0.1%.
_How does Locoid lotion work?_
Locoid lotion contains an adrenal cortex 
hormone (corticosteroid) and quickly 
decreases symptoms, such as itching, 
redness or scaling of the skin, which 
occur in certain skin disorders.
Corticosteroids in general do not cure 
the underlying disease.
_Authorization holder and manufacturer_
Marketing authorization holder 
Astellas Pharma Europe B.V.
Leiden, the Netherlands
Manufacturer
Temmler S.r.L Italia
Carugate (MI), Italy 
Locoid lotion is only available on 
prescription.
WHAT CAN LOCOID LOTION BE USED FOR?
Locoid lotion may be used for the 
treatment of superficial skin diseases  
in which itching, red
                                
                                Lire le document complet
                                
                            

Résumé des caractéristiques du produit

                                 
 
Page 1 of 6 
SUMMARY OF PRODUCT CHARACTERISTICS 
1. NAME OF THE MEDICINAL PRODUCT 
Locoid
®
 ointment 0.1% 
Locoid Lipocream
®
, cream 0.1% 
Locoid
®
 cream 0.1% 
Locoid Crelo
®
, cutaneous emulsion 0.1% 
Locoid
®
 scalp lotion 0.1% 
 
2. QUALITATIVE AND QUANTITATIVE COMPOSITION 
Locoid ointment and cream, Locoid Lipocream and Locoid Crelo
contain 1 mg/g and Locoid lotion 
1mg/ml hydrocortisone 17-butyrate. 
The ointment base is hydrophobic (fat); Locoid cream, Locoid
Lipocream and Locoid Crelo contain 
buffered oil-in-water emulsions (Locoid Lipocream contains more fat,
Locoid cream and Locoid 
Crelo more water). The lotion is buffered, somewhat viscous and
based on isopropanol-water. 
 
3. PHARMACEUTICAL FORM 
Ointment, cream, cutaneous emulsion and cutaneous solution. 
 
4. CLINICAL PARTICULARS 
4.1 THERAPEUTIC INDICATIONS 
Superficial, corticosteroid responsive dermatoses, which are not
caused by micro-organisms.  
Follow-up or maintenance treatment of dermatoses which have
been suppressed previously by a 
stronger corticosteroid. 
4.2 POSOLOGY AND METHOD OF ADMINISTRATION 
Apply 1-3 times daily a small amount of Locoid to the skin.  
After improvement of the disorder, application once daily or two
to three times a week is usually 
adequate. 
Do not use more than 30-60 g per week in general. 
Locoid should be applied evenly in a thin layer onto the diseased
skin. 
To promote penetration it may be lightly massaged into the skin. 
Occlusion may be necessary to obtain a better therapeutic result. 
 
 
Page 2 of 6 
4.3 CONTRAINDICATIONS 
-  Skin lesions caused by: 
o
  bacterial infections (e.g. pyodermias, luetic
and tuberculous processes) 
o
  viral infections (e.g. varicellae, herpes simplex, herpes zoster,
verrucae vulgares, verrucae 
planae, condylomata, mollusca contagiosa) 
o
  mycotic and yeast infections 
o
  parasitic infections (e.g. scabies) 
-  Ulcerous skin lesions, wounds 

                                
                                Lire le document complet
                                
                            

Rechercher des alertes liées à ce produit

Afficher l'historique des documents